舒利迭治疗中、重度儿童哮喘疗效观察  

Observation of curative effect of Seretide on moderate and severe child astham

作　　者：许红[1] 

机构地区：[1]安徽省宿州市立医院,安徽宿州234000

出　　处：《儿科药学杂志》2005年第2期31-32,共2页Journal of Pediatric Pharmacy

摘　　要：目的:观察舒利迭治疗中、重度儿童哮喘的疗效。方法:60例5～14岁中、重度哮喘患儿随机分成两组,根据病情严重程度观察组吸入舒利迭200μg、300μg;对照组吸入等量辅舒酮,共用12周,观察两组达到哮喘良好控制和全面控制标准的例数及半数达到哮喘良好控制和全面控制所需时间。结果:观察组在达到哮喘良好控制和全面控制标准的人数分别为29例(96.7%)和27例(90%),与对照组有显著差异(P<0.05);半数人达到哮喘良好控制和全面控制标准所需时间观察组较对照组明显缩短,两组有显著差异(P<0.01)。结论:舒利迭是治疗中、重度儿童哮喘的主要药物之一。Objective: To observe the curative effect of seretide on moderate and severe child astham. Methods: Sixty children between 5 and 14 years old who suffered from moderate and severe asthma were divided randomly into two groups. According to the patients' condition, the group under observation breathed in 200 μg to 300 μg seretide for twelve weeks, while the control subjects breathed in fluticasone of equal amounts. The numbers of the patients in each group whose condition got well controlled or completely controlled were observed, and the time needed was also observed for half of them. Results: The number of the group under observation was 29 (96.7%) and 27 (90%) respectively, which differs greatly with that of the control group (P < 0.05). The time needed for that in the group under observation was shorter than that of the control group. There was an obvious difference between two groups (P < 0.01). Conclusions: Seretide is one of the main drugs in treating moderate and severe child astham.

关 键 词：舒利迭 吸入 儿童哮喘 

分 类 号：R974.3[医药卫生—药品]